tential to approach the equilibrium potential for potas sium, typically about -85 m V (i.e., hyperpolarization). In contrast, closure of K+ channels will decrease the out ward movement of K+ and depolarize the membrane. Modest changes in membrane potential can be associated with large changes in diameter of cerebral arteries. For example, Fig. 1 illustrates that from a resting membrane potential of about -45 m V, hyperpolarization is associ ated with an increase in vessel diameter, whereas depo larization is associated with vasoconstriction. The result ing change in diameter of cerebral arteries is significant with even small changes in membrane potential . The concept illustrated in Fig. 1 is consistent with other studies that previously suggested a close relationship between membrane potential and ce rebral vascular tone (Fujiwara et aI., 1982; Harder and Waters, 1983; Knot et aI., 1996; Nagao and Vanhoutte, 1993) .
What is the resting membrane potential of vascular smooth muscle under normal conditions? To our knowl edge, membrane potential of cerebral vascular smooth muscle has not been measured in vivo. In other vascular beds (cremaster, mesenteric, and gracilis microcircula tions), membrane potential averages approximately -40 m V in vivo (Stekiel et aI., 1991) . In the cheek pouch microcirculation, membrane potential of endothelium and vascular smooth muscle was found to be -36 and -35 mY, respectively (Welsh and Segal, 1998) .
Many measurements of membrane potential have been made in cerebral vessels in vitro, and the values that have been obtained under baseline conditions have ranged from approximately -35 to -75 mY. This wide range of values was obtained under a variety of conditions (qui escent vessels, vessels with pharmacologically induced tone, pressurized arteries, etc.). We now know that in travascular pressure is an important determinant of rest ing membrane potential. For example, cerebral vascular smooth muscle depolarizes in response to increases in Measurements were obtained in arteries pressurized to 60 mm Hg. Data were redrawn from . Resting membrane potential in these arteries was approximately -45 mV.
See for details of how these values were obtained.
intravascular pressure in vitro (Brayden and Nelson, 1992; Harder, 1984; Harder et aI., 1989; Nel son, 1995, 1998) . Examination of data from cerebral ar teries that have been cannulated and pressurized to physiologic levels in vitro reveals that the range of val ues for membrane potential under resting conditions is more narrow (-36 to -54 mY) , and all but two studies report values between -36 and -46 mV (an average of -43 mY) (Brayden and Nelson, 1992; Brayden and Well man, 1989; Dietrich and Dacey, 1994; Harder, 1984; Harder et aI., 1987 Harder et aI., , 1989 Kauser et aI., 1990; Nelson, 1995, 1998; Nelson et aI., 1995 Nelson et aI., , 1997 Zimmer man et aI., 1997) . Isolated parenchymal arterioles (rest ing diameter of approximately 44 /-Lm) are the smallest vessels from the brain in which membrane potential has been measured in a pressurized preparation (Dietrich and Dacey, 1994) . The value for membrane potential ob tained in these arterioles (-38 mY) is similar to that measured in larger arteries under similar conditions. Thus, although measurements of membrane potential have not been made in cerebral blood vessels in vivo, the typical values obtained in pressurized cerebral arteries and arterioles studied in vitro are similar to those mea sured in other vascular beds in vivo (Stekiel et aI., 1991; Welsh and Segal, 1998) . As discussed earlier, resting membrane potential in vascular smooth muscle under in vitro conditions can vary considerably. This is noteworthy as the level of J Cereb Blood Flow Metab, Vol. 18, No. 10, 1998 resting membrane potential may be an important deter minant of responses to vasoactive stimuli. For example, the magnitude of hyperpolarization of vascular smooth muscle in response to acetylcholine (the classic endothe lium-dependent agonist) depends on the resting mem brane potential (Chataigneau et al., 1998a) . The level of resting membrane potential may also influence the effec tiveness of some inhibitors of K+ channels (Frey et aI., 1998) .
A wide variety of vasoactive stimuli have been shown to alter membrane potential of cerebral blood vessels in vitro (Fig. 2) . These stimuli include receptor-mediated agonists, second messengers, changes in pH, and syn thetic openers of K+ channels (substances such as cro makalim). In some vessels, inhibitors of K+ channels depolarize vascular smooth muscle as well. A few sub stances (norepinephrine and morphine) produce hyper polarization or depolarization depending on the prepara tion studied (Fallgren et aI., 1990; Harder et aI., 1981; Harder and Madden, 1984; Waters and Harder, 1983) .
Although membrane potential is an important deter minant of vascular tone (Fig, 1) , it should also be rec ognized that some vasoactive stimuli are capable of pro ducing relaxation or contraction of cerebral blood vessels with no apparent change in membrane potential. (Knot et aI., 1996) , adenosine diphosphate (ADP), adenosine triphosphate (ATP) (Chen and Suzuki, 1991; Brayden and Wellman, 1989) , vasoactive intestinal peptide (VIP) (Standen et aI., 1989) , calcitonin gene-related pep tide (CGRP) (Saito et aI., 1989) , adenosine (Nagao et aI., 1996) , substance P (Petersson et aI., 1995) , nitric oxide (NO) (McPher son and Stork, 1992; Rand and Garland, 1992; Zimmerman et aI., 1997) , acetylcholine (Brayden, 1990; Brayden and Wellman, 1989; Nishiye et aI., 1989; Standen et aI., 1989; Yamakawa et aI., 1997) , and acidosis (reduced pH) (Dietrich and Dacey, 1994) , In contrast, increases in intravascular pressure (blood pressure, BP) (Brayden and Nelson, 1992; Harder, 1984; Harder et aI., 1989; Nelson, 1995, 1998) , serotonin (5-HT) (Brayden and Wellman, 1989; Clark and Garland, 1993; Fujiwara et aI., 1982; Garland, 1987 Garland, , 1989 Harder, 1980; Harder et aI., 1981; Harder and Waters, 1983) , anoxia (Nagao and Vanhoutte, 1993) , endothelin (ET) {Jansan at aI., 1990; Kauser et aI., 1990; Salter and Kozlowski. 1995} . alkaloSis (increased pH) (Dietrich and Dacey. 1994; Harder and Madden. 1985) , neuropeptide Y (NPY) (Abel and Han. 1989; Fallg ren et aI., 1990) , histamine (Fallgren et aI., 1990) . and norepinephrine (NE) (Fallgren et aI., 1990; Gar land, 1989; Harder at at, 1981) have been reported to depolarize cerebral vessels.
ample, nitric oxide (NO) can produce marked relaxation of some blood vessels without changing membrane po tential (Brayden, 1990; Garland, 1993, 1994; Yamakawa et aI., 1997) . In addition, adenosine diphos phate (Brayden, 1991) , the calcium ionophore A23187 (Nishiye et aI., 1989 ), papaverine (Fujioka, 1984 , nica rdipine (Fujiwara and Kuriyama, 1983) , thromboxane A2 (Nishiye et aI., 1989; Fujioka et aI., 1986) , neuropeptide Y (Brayden and Conway, 1988) , and prostaglandin F2 ex (Fujiwara and Kuriyama, 1984) all have been reported to alter tone without altering membrane potential of cere bral arteries.
METHODS COMMONLY USED TO STUDY K+CHANNELS
Several approaches are used routinely to study K+ channels in blood vessels. Each method has distinctive strengths and provides useful information that often can not be obtained with any other method. Each method also has some potential limitations. One method involves the recording of current passing through individual ion chan nels using patch-clamp approaches. This is the most di rect measurement of K+-channel activity. This method can be insightful in establishing the presence or absence of specific K+ channels, as well as defining variables such as channel density and electrophysiologic charac teristics. However, the approach generally requires en zymatic digestion of vessels to obtain isolated myocytes. This procedure may injure cells, particularly extracellu lar and surface proteins. A recent extension of the patch clamp method has been applied to relatively intact cere bral arterioles (Quinn and Beech, 1998) . With this ap proach, the extent of enzymatic digestion of tissue is minimized, perhaps resulting in a closer approximation of the physiologic situation.
The fact that patch-clamping is typically done in iso lated myocytes may influence the outcome of some stud ies. An example of this is experiments that examine ef fects of NO on K+ channels. There is evidence that ef fects of NO and cyclic guanosine monophosphate (cGMP) (produced by soluble guanylate cyclase in re sponse to NO) (Fig. 3) on activity of K+ channels are much greater when endogenous levels of NO and cGMP are low, such as in the absence of endothelium or in the presence of inhibitors of NO synthase (see discussion below). Because isolated myocytes have no associated endothelium, NO and cGMP levels in these cells are necessarily low, so measurements are made in a system that may exhibit enhanced responses to NO. Under such conditions, it may be easier to observe positive effects of NO on K+ channels. This limitation may explain, in part, why positive effects of NO on activity of K+ channels are seen fairly consistently with patch-clamping of isolated myocytes but less frequently in intact cerebral vessels.
A second electrophysiologic approach to study K+ channels is measurement of membrane potential in intact but isolated vascular rings or segments. This approach is also used in isolated and pressurized cerebral arteries. Studies using vascular segments allow some cell-cell interactions to occur as they would normally. A major strength of this method is that it allows simultaneous measurements of membrane potential and vascular diam eter (or tone). Potential limitations of this approach in clude the fact that the majority of measurements have been made in nonpressurized vessels (which may be less physiologic). Even when arteries are studied under pres surized conditions, however, the vessels are almost never studied in the presence of blood flow (blood flow is probably an additional determinant of membrane poten tial), and no in vitro studies of cerebral vessels have included the use of pulsatile pressure and blood flow as occurs in vivo.
A third major approach in the study of K+ channels is to measure changes in tone or diameter of cerebral ves sels in response to activators or inhibitors of K+ chan nels. Many of these studies are performed in vivo (some include measurements of cerebral blood flow rather than changes in diameter of blood vessels) and thus have the strength of being the most directly relevant to normal regulation of cerebral blood flow. This approach may provide insight into the functional importance of a par ticular K+ channel. A potential limitation exists, how ever, in that mUltiple cell types are present and other mechanisms that influence vascular tone, such as endo thelium-dependent or neurohumoral mechanisms, are in tact in vivo. Thus, activators and inhibitors of K+ chan nels may potentially affect cells other than vascular smooth muscle, resulting in indirect effects on vascular tone and complicating interpretation of findings. Mem-brane potential is not generally measured, but it is as sumed to change in response to modulators of K+ chan nels in vivo. In addition, the use of high concentrations of KCI (used commonly to depolarize isolated vessels and implicate a hyperpolarization-dependent process) cannot be readily used in vivo because high concentrations of KCl cause cortical spreading depression. Despite these potential limitations, there are now many examples in which in vitro and in vivo approaches have produced results that support the same concept regarding K+ chan nels. Because each of these major approaches has unique strengths and limitations, we suggest that the most com plete understanding of K+ -channel function in cerebral blood vessels will be obtained by complementary in vitro and in vivo approaches.
The most recently developed approach for investiga tion of K+ channels involves studies at the molecular level (see discussion below). Very little data have been obtained regarding regulation of K+ channels at the gene and protein levels in the cerebral circulation (see Liu et aI., 1998 , for the single example). Such information will be essential to obtain a complete picture of mechanisms that control K+ -channel expression, distribution, and regulation.
TYPES OF K+ CHANNELS PRESENT IN CEREBRAL BLOOD VESSELS
Four types of K+ channels have been described in cerebral blood vessels. These are (1) calcium-activated (Brayden and Nelson, 1992; Nelson and Quayle, 1995; Song and Simard, 1995) , (2) A TP-sensitive (Kleppisch and Nelson, 1995; Standen et aI., 1989) , (3) voltage dependent (also called delayed rectifier) (Knot and Nel son, 1995; Nelson and Quayle, 1995) , and (4) inwardly rectifying K+ channels (Knot et aI., 1996; Quayle et aI., 1993 Quayle et aI., , 1997 . We will discuss each of these channels individually.
Calcium-activated K+ channels
As the name indicates, calcium-activated K+ channels are activated by increasing levels of intracellular cal cium. This type of K+ channel may also be activated by membrane depolarization, although this mechanism also requires calcium at physiologic membrane potentials. Calcium-activated K+ channels are thought to be the most abundant in vascular smooth muscle, with up to lO4 channels estimated to be present per cell (Nelson and Quayle, 1995) .
Activity of calcium-activated K+ channels can be in hibited using tetraethylammonium ion (TEA). Concen trations of TEA of less than or equal to 1 mmol/L are thought to be selective for the calcium-activated K+ channel (Kitazono et aI., 1995; Nelson and Quayle, 1995) . Calcium-activated K+ channels are also inhibited by charybdotoxin or iberiotoxin, with the latter toxin thought to be highly selective (K itazono et aI., 1995; Nelson and Quayle, 1995) (Fig. 4) . Activity of this ion channel is not inhibited by commonly used concentra tions of gJibenclarnide or relatively low concentrations of barium ion (used to inhibit ATP-sensitive and inwardly rectifying K+ channels, respectively) (Nelson and Quayle, 1995) . In contrast to pharmacologic inhibitors, discovery of selective openers of calcium-activated K+ channels has been slow. NS-1619 has been used in sev eral studies as an activator of calcium-activated K+ chan nels. Although NS-1619 produces relaxation of cerebral arteries through a mechanism that may partially involve opening of calcium-activated K+ channels, this com pound has other vasoactive effects, including inhibition of calcium channels (Holland et aI., 1996a) , that may complicate interpretation of experimental findings.
An important function of calcium-activated K+ chan nels may be to act as a buffering system in vascular smooth muscle to limit contraction. The best-studied ex ample of this mechanism relates to the myogenic re sponse. Elevations in arterial pressure produce mem brane depolarization, increases in intracellular calcium levels, and vasoconstriction (Brayden and Nelson, 1992; Knot et aI., 1998) . Calcium activated K+ channels are activated in response to mem brane depolarization and increases in intracellular cal cium (including calcium sparks), resulting in hyperpo larization, which acts as a negative feedback mechanism to limit vasoconstriction (Brayden and Nelson, 1992; Knot et aI., 1998; . ;' @1 ��;
Summary of mechanisms by which calcium-activated K+ channels produce relaxation of vascular smooth muscle. Cal cium-activated K+ channels are composed of (Y-and f3-subunit proteins (see text). In addition to activation by intracellular cal cium (Ca2+) and membrane depolarization (not shown), calcium activated K+ channels may be activated by cyclic adenosine monophosphate (cAMP) or cGMP. Calcium sparks from sarco plasmic reticulum (SR), produced in response to cAMP or cGMP, may also activate this ion channel. These K+ channels are inhib ited by tetraethylammonium (TEA) or iberiotoxin. Activation of K+ channels results in K+ efflux from the cell, hyperpolarization of the cell membrane, and closure of voltage-gated Ca2+ channels. Clo sure of Ca2+ channels reduces intracellular levels of Ca2+, pro ducing relaxation of vascular smooth muscle.
In addition to modulating vasoconstrictor responses, calcium-activated K+ channels appear to play a major role as a mediator of vasodilation (see below) (Fig. 4) . Activity of calcium-activated K+ channels also appears to influence resting tone of cerebral vessels, particularly in larger vessels. In cerebral arteries, inhibitors of cal cium-activated K+ channels produce contraction in vitro (Brayden and Nelson, 1992; Geary et a!., 1997; Gokina et aI., 1996) and in vivo (Fujii et a!., 1991; Sobey and Faraci, 1997b) . In cerebral arterioles in vivo, these same inhibitors have no effect on vessel diameter or produce very modest vasoconstriction (reviewed in Faraci and Heistad, 1998) . Thus, one interpretation of these findings is that the influence of calcium-activated K+ channels on resting tone varies along the vascular tree and may be more important in cerebral arteries than in cerebral mi crovessels. In addition, recent pharmacologic and patch clamp evidence suggest that calcium-activated K+ chan nels are silent in small arterioles outside the brain under basal conditions (Jackson and Blair, 1998) . These data suggest that calcium-activated K+ channels in very small arterioles may have a relatively low calcium sensitivity. Because of this characteristic, these ion channels may not be active at rest in the smaller microvessels (Jackson and Blair, 1998) .
A novel mechanism related to the activation of cal cium-activated K+ channels in cerebral arteries involves calcium 'sparks' (Fay, 1995; . Cal cium sparks are localized elevations in intracellular cal cium caused by ryanodine-sensitive calcium release events (Nelson et aI., 1995) . These subcellular calcium sparks are triggered by activation of sarcoplasmic reticu lum calcium-release channels that are in close proximity to calcium-activated K+ channels in the cell membrane (Fay, 1995) (Fig. 4) . Thus, regulation of the frequency or amplitude of calcium sparks may be an important mecha nism to control local activation of calcium-activated K+ channels and thus mediate vasodilation and modulate vasoconstriction (Nelson et aI., 1995; Porter et aI., 1998) . For example, activators of protein kinase C produce con traction of cerebral arteries. At least part of the mecha nism that produces this effect may involve a decrease in frequency of calcium sparks in cerebral vascular smooth muscle resulting in closure of calcium-activated K+ channels and depolarization (Bonev et aI., 1997) .
ATP-sensitive K+ channels
The characteristics and functional importance of ATP sensitive K+ channels in blood vessels has been reviewed in detail recently (Quayle et aI., 1997) . One key charac teristic of these ion channels is that their activity may reflect the metabolic state of the cell. As the name indi cates, these K+ channels are sensitive to intracellular ATP, which inhibits channel activity (Nelson and Quayle, 1995) . Dissociation of ATP from the channel results in channel opening and membrane hyperpolariza tion. Other metabolically related stimuli, including re ductions in P02 or pH, also open the channel and produce vasorelaxation (Quayle et a!., 1997) (Fig. 5) . It is esti mated that a few hundred ATP-sensitive K+ channels are present per cell in arteries (Quayle et a!., 1997) . Al though this number is much less than that for calcium activated K+ channels, recall that opening of only a few K+ channels is sufficient to alter membrane potential (see above).
Activity of ATP-sensitive K+ channels is inhibited by sulfonylureas, such as glibenclamide (Kitazono et aI., 1995; Kleppisch and Nelson, 1995; Nelson and Quayle, 1995; Standen et aI., 1989) (Fig. 5) . Glibenclamide ap pears to be a selective inhibitor (in relation to effects on other K+ channels) of ATP-sensitive K+ channels at the most commonly used concentrations (�3 f.Lmol/L), and has been used widely to examine the functional role of these ion channels in cerebral vessels. The selectivity and mechanism of action of glibenclamide has been reviewed in detail (Quayle et a!., 1997) .
Unlike the situation for other K+ channels, there are many pharmacologic activators of A TP-sensitive K+ channels ("K+ -channel openers" ) (Kitazono et aI., 1995) (Fig. 5 ). These activators of K+ channels (levcromaka lim, pinacidil, and nicorandil, for example) produce a hyperpolarization of cerebral arteries (Edwards et aI., 1996; Harder et aI., 1987; Kleppisch and Nelson, 1995; Nagao et aI., 1996; Petersson et aI., 1995; Plane and Garland, 1993) that is inhibited by glibenclamide (Ed wards et a!., 1996; Kleppisch and Nelson, 1995; Nagao et aI., 1996; Plane and Garland, 1993) . There is now a large body of data regarding functional effects of activators of ATP-sensitive K+ channels in cerebral blood vessels. Ac-
Glibenclamide Ca++
Cromakalim � e channels produce relaxation of vascular smooth muscle. ATP sensitive K+ channels are composed of subunit proteins-an in wardly rectifying K+ channel (K'A) and a sulfonylurea receptor (SUR). These K+ channels may be activated by several stimuli including reductions in intracellular ATP, pH, or Po 2 , or increases in cAMP. Synthetic "K+-channel openers" such as cromakalim also activate this ion channel. ATP-sensitive K+ channels are inhibited by glibenclamide. Activation of K+ channels results in K+ efflux from the cell, hyperpolarization of the cell membrane, and closure of voltage-gated Ca2+ channels. Closure of Ca2+ chan nels reduces intracellular levels of Ca2+, producing relaxation of vascular smooth muscle.
tivators of ATP-sensitive K+ channels produce relaxation of cerebral arteries and arterioles in vitro (reviewed in Faraci and Heistad, 1998) . This same response is present in human cerebral arteries (Hempelmann et aI., 1995; Peters son et ai., 1995; Thorin et ai., 1998) . Activators of ATP-sensitive K+ channels cause dilation of the basilar artery and cerebral arterioles in vivo (reviewed in Faraci and Heistad, 1998) . Furthermore, intraparenchymal in jection of cromakalim produces a glibenc1a mide sensitive increase in local cerebral blood flow (Reid et ai., 1995) . Thus, there is strong evidence that ATP sensitive K+ channels are present and functional in both large cerebral arteries and the cerebral microcirculation. Because glibenclamide does not produce depolarization or constriction of cerebral arteries in the vast majority of studies (reviewed in Faraci and Heistad, 1998) , it seems unlikely that activity of ATP-sensitive K+ channels modulates resting tone.
Voltage-dependent K+ channels
Like calcium-activated K+ channels, voltage dependent K+ channels are activated in response to mem brane depolarization, but this process occurs independent of the intracellular calcium concentration. Activity of voltage-dependent K+ channels can be inhibited fairly selectively using low concentrations of 4-aminopyridine «1 mmol/L) Nelson and Quayle, 1995) . Because both voltage-dependent and cal cium-activated K+ channels are activated by depolariza tion, 4-aminopyridine can be used to distinguish re sponses mediated by either channei. Tetraethylammoni um is a poor inhibitor of voltage-dependent K+ channels unless very high concentrations are used (Nelson and Quayle, 1995) . Voltage-dependent K+ channels can also be inhibited by dendrotoxin (Kitazono et ai., 1995) . The estimated number of voltage-dependent K+ channels per cell in arteries is about 10 3 (Nelson and Quayle, 1995) .
Compared with the two K+ channels discussed previ ously, much less is known about the functional impor tance of voltage-dependent K+ channels. 4-Amino pyridine depolarizes cerebral vascular smooth muscle and constricts cerebral arteries , suggesting that activity of voltage-dependent K+ chan nels influences resting cerebral vascular tone. These K+ channels are also activated by increases in arterial blood pressure . Recent studies sug gest that activation of voltage-dependent K+ channels may contribute to mechanisms that produce cerebral va sorelaxation in response to NO and endothelium-derived hyperpolarizing factor (EDHF) (Dong et ai., 1998 ; Pe tersson et a!., 1997a).
Inwardly rectifying K+ channels
Known properties of inwardly rectifying K+ channels in cerebral arteries are described in detail by Quayle et ai. (1997) . These K+ channels are inhibited by relatively low J Cereb Blood Flow Metab, Vol. 18, No. 10, 1998 concentrations of external barium ion. Barium is consid ered to be the most effective and selective inhibitor of inwardly rectifying K+ channels (Quayle et ai., 1997) . 4-Aminopyridine and TEA are relatively weak inhibi tors, whereas glibenclarnide and charybdotoxin produce almost no inhibition (Nelson and Quayle, 1995) .
Low concentrations of barium produce contraction of cerebral arteries in vitro suggesting that activity of in wardly rectifying K+ channels affects resting tone (Johnson et ai., 1998; Knot et ai., 1996) . Although it is known that high concentrations of barium constrict ce rebral arterioles in vivo (Rosenblum, 1985) , we are not aware of in vivo studies that have used concentrations of barium thought to be selective for inwardly rectifying K+ channels. The estimated number of inwardly rectifying K+ channels per cell in arteries is estimated at a few hundred (Nelson and Quayle, 1995) .
MOLECULAR BIOLOGY
Studies using molecular biology are revealing a large diversity in the subtypes of K+ channels that are ex pressed in vascular smooth muscle. Potassium channels are often composed of multiple gene products and com plexes of proteins. For example, calcium-activated K+ channels consist of ex-and [3-subunit proteins (Kaczo rowski et ai., 1996; Tseng-Crank et ai., 1996) . The ex subunit forms the ion-conduction pore of the channel and the [3 subunit is a membrane-spanning protein that acts as a regulatory component of the channel (Fig. 4) . The [3 subunit is important in conferring calcium sensitivity to the channel (Jan and Jan, 1997) as well as sensitivity to inhibition by TEA and iberiotoxin (Kaczorowski et ai., 1996; McCobb et a!., 1995) .
ATP-sensitive K+ channels are also a complex of pro teins consisting of a pore-forming subunit (a member of the inwardly rectifying K+ -channel family) (K1R) and the sulfonylurea receptor (SUR) (Quayle et ai., 1997; Trapp and Ashcroft, 1997) (Fig. 5) . The pore-forming subunit also serves as the sensor for A TP (Trapp and Ashcroft, 1997) . As the name indicates, the sulfonylurea receptor is responsible for glibenclamide sensitivity of the chan nel and is probably the site that confers sensitivity of ATP-sensitive K+ channels to openers such as pinacidil and diazoxide (Quayle et aI., 1997; Trapp and Ashcroft, 1997) . In total, four sulfonylurea receptor subunits plus four pore-forming subunits are required to make a func tional ATP-sensitive K+ channel (Trapp and Ashcroft, 1997) .
More than one type of sulfonylurea receptor and more than one type of inwatdly rectifying K+ channel are now known to exist (Babenko et aI., 1998; Yokoshiki et a!., 1998) . There is also heterogeneity in the properties of ATP-sensitive K+ channels in different cell types, and this heterogeneity may be caused in part by differences in subunit proteins that make up the channel (Babenko et aI., 1998) . For example, ATP-sensitive K+ channels in vascular smooth muscle seem to be composed of SUR2B with either KJR6.1 or K1R6.2, whereas other tissues such as heart and pancreas may express other combinations of KIR and SUR subtypes (Babenko et aI., 1998; Isomoto et al., 1996; Trapp and Ashcroft, 1997; Yokoshiki et aI., 1998) . It is noteworthy that the sulfonylurea receptor can couple to different types of inwardly rectifying K+ chan nels (Ammana et aI., 1996) . This characteristic may con fer sensitivity to glibenclamide in K+ channels that are not ATP-sensitive. Thus, the presence of glibenclamide sensitivity implicates a K+ channel but does not neces sarily indicate the presence of an ATP-sensitive K+ chan nel (Quast, 1996) . In contrast to the calcium-activated and ATP-sensitive K+ channels, which are composed of protein complexes within the cell membrane, voltage dependent K+ channels consist of a pore-forming ex sub unit and a cytoplasmic regulatory f3 subunit (Rettig et aI., 1994) . Multiple ex and f3 subunits for voltage-dependent K+ channels may be expressed in vascular smooth muscle (Yuan et aI., 1998b) .
Expression of K+ channels may not be homogeneous throughout the circulation. For example, the K v 1.2 and Kv2.1 subtypes of voltage-dependent K+ channels are expressed to a greater extent in large arteries in lung, whereas Kv1.3 is present only in pulmonary resistance arteries (Patel et aI., 1997) . To our knowledge, there are no data at the molecular level regarding the regional or segmental distribution of K+ channels within the cerebral circulation.
Relatively little is known about factors that regulate expression of K+ -channel proteins in vascular smooth muscle, or about the promoter regions for these genes. Recent evidence suggests that vascular expression of K+ channel proteins may change with hypertension (Liu et aI., 1998; Yuan et aI., 1998a) and hypoxia (Wang et aI., 1997) . For example, mRNA and protein for voltage dependent K+ channel subunits (Kv1.2 and Kv 1.5) are decreased in response to hypoxia (Wang et aI., 1997) .
VASOACTIVE STIMULI Nitric oxide
Nitric oxide plays a major role in regulation of cere bral vascular tone (reviewed in Faraci and Heistad, 1998) . Nitric oxide is a potent dilator of cerebral blood vessels (Faraci and Heistad, 1998) , and there are three sources of NO in brain (Fig. 3) . Two of these sources, endothelial and neuronal isoforms of NO synthase (eNOS and nNOS, respectively), are expressed in a con stitutive manner (Faraci and Brian, 1994) . The third source is the inducible isoform of NO synthase (iNOS). Inducible NO synthase is not expressed under normal conditions in most cells but can be expressed in all major cell types (endothelium, vascular smooth muscle, neu rons, and glia) in response to a variety of stimuli (primarily proinflammatory stimuli) (Faraci and Brian, 1994; Faraci and Heistad, 1998) .
In general, there are two ways in which NO can pro duce relaxation of vascular smooth muscle-soluble guanylate cyclase-dependent or soluble guanylate cycla se-independent mechanisms. Both mechanisms can po tentially involve activation of K+ channels (Fig. 3) . Soluble guanylate cyclase, a heme-containing protein with a high affinity for NO, is responsible for the enzy matic conversion of guanosine-5'-triphosphate to cyclic guanosine-3' ,5'-monophosphate (cGMP) (Hobbs, 1997) (Fig. 3) . Submicromolar concentrations of NO evoke large increases in activity of soluble guanylate cyclase. For this concentration range of NO, the major cellular response is thought to be activation of soluble guanylate cyclase (Lincoln et aI., 1996; Mayer and Hemmens, 1997) . This mechanism occurs in cerebral blood vessels as well, where NO and NO donors produce marked in creases in cGMP levels and vasorelaxation (Brian et aI., 1994; Homayoun et aI., 1989; Katusic et aI., 1989; Kim et a!., 1992; Onoue and Katusic, 1997 , 1998a , 1998b Pearce et aI., 1994; Yang et a!., 1991a) . Several lines of evidence, including studies using inhibitors of soluble guanylate cyclase, suggest that relaxation of cerebral blood vessels (large arteries and microvessels) in re sponse to NO is mediated predominantly by soluble gua nylate cyclase (Dong et aI., 1998; Jiang et a!., 1998; Meng et aI., 1998; Onoue and Katusic, 1998b; Sobey and Cocks, 1998; Sobey and Faraci, 1997 a; Yang and Iadecola, 1998) (Fig. 3) .
Although soluble guanylate cyclase appears to medi ate the majority of cerebral vasorelaxation in response to NO, there is a component of the response that is not abolished by inhibitors of soluble guanylate and thus is presumably mediated by other mechanisms. These latter mechanisms may include direct activation of K+ chan nels by NO (Bolotina et aI., 1994) (Fig. 3) , inhibition of 20-hydroxyeicosatetraenoic acid formation (suggested to occur in kidney blood vessels) (Alonso-Galicia et aI., 1997), and inhibition of calcium-stimulated chloride cur rent resulting in hyperpolarization (Zhang et aI., 1997) .
The role of K+ channels in mediating relaxation of cerebral blood vessels to NO has been somewhat diffi cult to fully define. Under some conditions and in some blood vessels, activation of K+ channels appears to con tribute to vasorelaxation in response to NO (Fig. 3) . However, there are examples in which K+ channels do not appear to be involved in the vasodilator effects of NO.
In patch-clamp studies of isolated myocytes from ce rebral arteries, NO, NO donors, and cGMP increase ac tivity of calcium-activated K+ channels (Hoang and Mathers, 1998; Holland et a!., 1996b Holland et a!., , 1997a Holland et a!., , 1997b Holland et a!., , 1997c Robertson et aI., 1993) . The study by Robertson et ai. (1993) provided the first direct evidence that F. M. FARACl AND C. G. SOBEY NO can activate calcium-activated K+ channels in cere bral vascular smooth muscle. This same response was not observed in isolated patch preparations (in which cytosolic enzymes are not present), providing some evi dence against direct effects of NO on this ion channel (Holland et aI., 1997 b, 1997 c). Although these studies provided evidence that NO is capable of activating K+ channels under some conditions, the technique used did not provide insight into whether this mechanism is func tionally important in intact cerebral vessels.
Hyperpolarization in response to NO has been ob served in cerebral blood vessels. For example, NO do nors produce modest hyperpolarization in some prepara tions (Zimmerman et aI., 1997) , but the effect is some times only seen in response to very high concentrations of NO (McPherson and Stork, 1992; Rand and Garland, 1992) . Nitric oxide may also activate calcium sparks, which open local calcium-activated K+ channels (Porter et aI., 1998) . Hyperpolarization in response to NO has also been observed in the carotid artery (Cohen et aI., 1997; Corriu et aI., 1996a) . In addition, vasorelaxation in response to NO, NO donors, or cGMP can be attenuated by inhibitors of K+ channels (inhibitors of calcium activated K+ channels in most studies) consistent with a role for K+ channels in NO-mediated hyperpolarization (Dong et aI., 1998; Jiang et aI., 1998; Onoue and Katusic, 1997 , 1998a , 1998b Paterno et aI., 1996; Sobey and Faraci, 1997b) . It should be noted however, that many of these findings were observed using vessels without en dothelium (Dong et aI., 1998; Jiang et aI., 1998; Onoue and Katusic, 1997 , 1998a , 1998b or in intact vessels in the presence of inhibitors of NO synthase (Murphy and Brayden, 1995; Sobey and Faraci, 1997b) or soluble gua nylate cyclase (Onoue and Katusic, 1998h) . For example, charybdotoxin produced modest inhibition of vasorelax ation in response to DEA-NONOate (an NO donor), and the inhibitory effect was more pronounced after inhibi tion of soluble guanylate cyclase (Onoue and Katusic, 1998b) . These findings provide some evidence that high concentrations of NO may activate K+ channels indepen dent of activation of soluble guanylate cyclase and pro duction of cGMP (Onoue and Katusic, 1998b) (Fig. 3) .
There are also negative data in regards to effects of NO on K+ channels. In some studies, for example, NO has no effect on membrane potential of cerebral arteries but produces marked relaxation (Brayden, 1990; Murphy and Brayden, 1995; Garland, 1993, 1994 ; Ya makawa et aI., 1997). There are also examples in which inhibitors of calcium-activated K+ channels do not affect vasorelaxation in response to NO (Armstead, 1997c; Sobey et aI., 1996; Sobey and Faraci, 1997b; Taguchi et aI., 1995b; Wellman and Bevan, 1995) .
Basal production of NO exerts a tonic influence on resting vascular tone throughout the brain, but particu larly in large cerebral arteries (Faraci, 1991 Heistad, 1998). Part of this basal vasodilator effect may include an effect of NO on K+ channels. Recent mea surements indicate that membrane depolarization occurs in the middle cerebral artery in response to inhibition of NO synthase, suggesting that basal NO produces tonic hyperpolarization (Zimmerman et aI., 1997; Peng et aI., 1998) . Based on the majority of available data, we hy pothesize that the following mechanism may be present. Nitric oxide can activate K+ channels under conditions in which NO production or cGMP levels are low. Thus, the basal dilator influence of NO on cerebral vessels may be mediated, in part, by activation of K+ channels. Activa tion of K+ channels may also contribute to vasorelaxation in response to additional NO (levels of NO greater than those produced under basal conditions) in some, but not all, preparations. Exogenous NO may therefore be more likely to activate K+ channels after endothelial removal, during inhibition of NO synthase, and perhaps during pathophysiologic conditions associated with impairment of NO signaling.
Endothelium-dependent hyperpolarizing factor
In addition to NO, the endothelium can produce other relaxing factors including dilator prostanoids and EDHF. Some investigators use the term "EDHF" when refer ring to an endothelium-derived relaxing factor that is not NO or a product of cyclooxygenase. Recent evidence suggests that this assumption has a potential limitation because it can be difficult to completely inhibit produc tion of NO in endothelium (Cohen et aI., 1997 ). An al ternative definition is that any vasoactive factor pro duced by endothelium and which produces hyperpolar ization of vascular smooth muscle (including NO) can be classified as an EDHF. Although there may be several such mediators in cerebral blood vessels, it is widely believed that the most likely mechanism of EDHF mediated hyperpolarization of vascular smooth muscle is by activation of K+ channels (Cohen and Vanhoutte, 1995; Garland et aI., 1995; Mombouli and Vanhoutte, 1997) .
Several studies have described hyperpolarization of cerebral arteries in response to endothelium-dependent stimuli including acetylcholine (Brayden, 1990; Brayden and Wellman, 1989; Nishiye et aI., 1989; Standen et aI., 1989; Yamakawa et aI., 1997) and substance P (Peters son et aI., 1995) . Not all endothelium-dependent agonists hyperpolarize cerebral vessels however, as A23187 and adenosine diphosphate can produce marked vasorelax ation but no hyperpolarization (Brayden, 1991; Nishiye et aI., 1989) .
To examine the functional importance of EDHF mediated mechanisms of endothelium-dependent relax ation, effects of inhibitors of K+ channels on responses of cerebral blood vessels to endothelium-dependent ago nists have been tested. Unfortunately, the findings ob-tained in these studies have been variable, and there is currently no consensus regarding the functional impor tance of EDHF in brain. When an EDHF has been im plicated, there is also no consensus regarding which K+ channels mediate the vasoactive effect. For example, re laxation of cerebral vessels in response to acetylcholine has been reported to be inhibited by glibenclamide (Brayden, 1990; Faraci et aI., 1994; Standen et aI., 1989) , apamin (an inhibitor of small conductance calcium activated K+ channels (Yamakawa et aI., 1997) , or in hibitors of calcium-activated K+ channels (Dong et aI., 1998; Peters son et aI., 1997a; Wellman and Bevan, 1995) . In some studies, the combination of charybdo toxin and apamin was much more effective in reducing responses to acetylcholine than either inhibitor alone (Corriu et aI., 1996a; Peters son et aI., 1997a) . These differences may occur because of regional, segmental, or species differences in the models studied. Another in consistency is that some, but not all, studies have been performed in the presence of inhibitors of cyclooxygen ase and NO synthase.
A key point in the characterization of EDHF relates to the suggestion that EDHF may only be produced after inhibition of NO synthase. Recent evidence suggests that NO may inhibit formation or activity of EDHF (Bauer sachs et aI., 1996) . Thus, EDHF may have a limited role under normal conditions, but may become functionally much more important after pharmacologic inhibition of NO synthase, or in disease states that are associated with impairment of the NO-cGMP signaling pathway.
To assess the functional importance of a non-NO EDHF, it is therefore necessary to determine whether a significant endothelium-dependent response remains in the presence of inhibition of NO synthase. In the brain, most studies have found inhibitors of NO synthase to be very effective in reducing responses to acetylcholine along the entire vascular tree. For example, relaxations in response to acetylcholine in the carotid and basilar ar teries, as well as in pial and parenchymal arterioles, are greatly reduced by inhibitors of NO synthase (reviewed in Faraci and Heistad, 1998) . Increases in parenchymal blood flow in response to acetylcholine are also mark edly reduced by inhibitors of NO synthase (Iadecola and Zhang, 1996; Yang and Chang, 1998) . Some studies sug gest that a component of endothelium-dependent relax ation of the carotid artery is mediated by a non-NO EDHF (Lischke et aI., 1995a (Lischke et aI., , 1995b . In contrast, other data, including studies using mice that are deficient in expression of the gene for endothelial NO synthase, sug gest the entire response to acetylcholine is mediated by NO (Cohen et aI., 1997; Faraci et aI., 1998) . Relaxation of human pial arteries in response to substance P is also largely NO mediated, but an EDHF may contribute in arteries from some individuals (Peters son et aI., 1995) . These findings do not exclude the possibility that NO itself acts as an EDHF (Cohen et aI., 1997) . Despite NO being the major mediator of vasorelaxation in response to acetylcholine in most studies, portions of the response to acetylcholine appear to be mediated by other mecha nisms. For example, in basilar arteries of the guinea pig, relaxation in response to acetylcholine is not attenuated by inhibitors of NO synthase or soluble guanylate cy clase (Peters son et aI., 1997a; Zygmunt et aI., 1997) .
Some data from vessels other than cerebral arteries suggest that one EDHF is an epoxyeicosatrienoic acid (EET), a product of cytochrome P450 metabolism of arachidonic acid. This hypothesis is controversial, how ever, with evidence both for (Arima et aI., 1997; Bauer sachs et aI., 1994; Campbell et aI., 1996; Lischke et aI., 1995a Lischke et aI., , 1995b Chen and Cheung, 1996; Dong et aI., 1997) and against (Cohen et aI., 1997; Corriu et aI., 1996a Corriu et aI., , 1996b Urakami-Harasawa et aI., 1997; Van de V oorde and Vanheel, 1997; Vanheel and Van de V oorde, 1997 ) a role for EET as a mediator of endothelium dependent hyperpolarization (reviewed in Mombouli and Vanhoutte, 1997) .
There is relatively little information regarding the va soactive effects and functional importance of EET in the cerebral circulation. Studies examining vasoactive ef fects of EET have produced mixed results. Relaxation of the middle cerebral artery has been observed in response to 5,6-EET, 8,9-EET, and 11,12-EET in vitro, and re sponses to 1l,12-EET were inhibited by a high concen tration of TEA (30 mmol/L), suggesting activation of a K+ channel was involved (Gebremedhin et aI., 1992). 14,15-Epoxyeicosatrienoic acid enhances outward K+ current in isolated myocytes from cerebral microvessels consistent with activation of a K+ channel (Alkayed et a!., 1996) . 5,6-Epoxyeicosatrienoic acid, 8,9-EET, 11,12-EET, and 14,15-EET all produce dilation of cere bral arterioles in newborn pigs with 5,6-EET being the most active (Leffler and Fedinec, 1997) . In contrast, Ellis et ai. (1990) reported that several EET (8,9-EET, 11,12-EET, and 14,15-EET) have little or no effect on diameter of cerebral arterioles in vivo, with the exception of 5,6-EET. In the carotid artery, EET (5,6-EET, 8,9-EET, 11,12-EET, and 14,l5-EET) do not change membrane potential or affect vascular tone in vitro (Chataigneau et aI., 1998a) .
A potential limitation in attempting to define the func tional role of EET relates to nonspecific effects of com monly used inhibitors of the cytochrome P450 pathway (the antifungal imidazoles) (Mombouli and Vanhoutte, 1997) . These substances reportedly have several nonspe cific effects unrelated to inhibition of the P450 pathway, including direct inhibition of K+ channels and NO syn thase (Alvarez et aI., 1992; Popp et aI., 1996; Ritten house et aI., 1997; Vanheel and Van de Voorde, 1997;  Van de Voorde and Wolff et aI., 1993; Yuan et aI., 1995) .
Very little is known regarding potential endothelial production of EET in the cerebral circulation. In cerebral arteries in vitro, relaxation in response to acetylcholine was not inhibited by 17 -octadecynoic acid, ETY A (5,8,11,14-eicosatetraynoic acid, a nonselective inhibitor of arachidonic acid metabolism), or clotrimazole, sug gesting no role for cytochrome P450 metabolism of ara chidonic acid (Dong et aI., 1998; Peters son et aI., 1997a) . Leffler et aI. (1997) have provided some evidence that endothelium-derived EET may contribute to dilation of cerebral arterioles during hypoxia in piglets.
It has recently been suggested that anandamide, an endogenously produced cannabinoid (derived from ara chidonic acid) may be an EDHF (Randall and Kendall, 1998) . Although anandamide can produce dilation of ce rebral arterioles (Ellis et aI., 1995), whether it functions as an EDHF in the cerebral circulation is not known. Initial evidence suggests that anandamide does not alter membrane potential and that endothelium-dependent hy perpolarization of the carotid artery is not mediated by activation of cannabinoid receptors (Chataigneau et aI., 1998b; Holland et aI., 1997a) . Furthermore, in the basilar artery of the guinea pig, relaxation in response to ace tylcholine is not inhibited by an antagonist of cannabi noid receptors, suggesting EDHF is not an endogenously produced cannabinoid (Peters son et aI., 1997 b).
Cyclic adenosine monophosphate
In addition to cGMP, production of cyclic adenosine monophosphate (cAMP) in vascular smooth muscle is a major second messenger system that influences vascular tone. A wide variety of vasoactive stimuli are known to activate adenylate cyclase resulting in increased produc tion of cAMP in blood vessels. These stimuli include receptor-mediated agonists (adenosine, vasoactive intes tinal polypeptide, calcitonin gene-related peptide [CGRP), prostacyclin, isoproterenol, and adrenomedul lin) and forskolin (a direct activator of adenylate cyclase) (reviewed in Faraci and Heistad, 1998) . Activation of K+ channels appears to be a key mechanism that mediates cAMP-dependent vasorelaxation (Figs. 4 and 5) .
The concept that relaxation of cerebral blood vessels in response to stimuli that increase cAMP is mediated by activation of K+ channels is based on several lines of evidence. First, studies using patch-clamping demon strated that isoproterenol, forskolin, and cAMP increase current passing through calcium-activated K+ channels (Song and Simard, 1995) . Adenosine and CGRP increase glibenclamide-sensitive current in cerebral arteries, con sistent with activation of ATP-sensitive K+ channels (Kleppisch and Nelson, 1995) . Second, forskolin and cAMP increase the frequency of calcium sparks, which activate calcium-activated K+ channels in cerebral arter ies (Porter et aI., 1998) . Relaxation of cerebral arteries in response to forskolin is inhibited by ryanodine, an in-J Cereb Blood Flow Metab, Vol. 18, No. 10, 1998 hibitor of calcium sparks (Porter et aI., 1998) (Fig. 4) . Third, adenosine (Nagao et aI., 1996) , CGRP (Saito et aI., 1989) , prostacyclin (Corriu et aI., 1996a; Dong et aI., 1998) , vasoactive intestinal peptide (Standen et aI., 1989) , and cAMP (Chen and Suzuki, 1991) hyperpolar ize cerebral arteries. Fourth, relaxation of cerebral ves sels in response to forskolin (Bari et aI., 1997; Dong et aI., 1998; Kitazono et aI., 1993a; Taguchi et aI., 1995b) , cAMP (Armstead, 1997b; Paterno et aI., 1996; Taguchi et aI., 1995b) , CGRP (Armstead, 1997a; Hong et aI., 1996; Kitazono et aI., 1993b; Louis et aI., 1996) , aden osine (Armstead, 1997e; Bari et aI., 1998; Paterno et aI., 1996) , prostacyclin (Bari et aI., 1996; Dong et aI., 1998; Fredricks et aI., 1994) , norepinephrine (Kitazono et aI., 1993a) , adrenomedullin (Lang et aI., 1997) , and pituitary adenylate cyclase-activating peptide (Armstead, 1997 d) are attenuated by inhibitors of K+ channels. Fifth, relax ation of cerebral arteries in response to forskolin is in hibited by precontracting arteries with high concentra tions of KCl, which prevents hyperpolarization in re sponse to activation of K+ channels (Dong et aI., 1998; Porter et aI., 1998) . Taking all these findings into ac count, there is strong evidence that relaxation of cerebral vessels to cAMP is mediated by activation of K+ chan nels (Figs. 4 and 5) .
Potassium ion
Normal concentrations of K+ in cerebrospinal fluid or brain extracellular fluid are approximately 3 mmol/L (Davson et aI., 1987) . In contrast to the depolarization and contraction of vascular smooth muscle that is com monly produced by high concentrations of K+, small to moderate increases in the concentration of extracellular K+ produce membrane hyperpolarization (Fig. 2) and relaxation of cerebral arteries in vitro (Johnson et aI., 1998; Knot et aI., 1996) and dilation of cerebral arteries and arterioles in vivo (Fujii et aI., 1990; Kuschinsky et aI., 1972) . Because K+ is released during neuronal acti vation, this mechanism may play a role in the coupling of cerebral metabolism and local blood flow.
Potassium-induced vasodilation is generally thought to be endothelium-independent and not attenuated by in hibitors of ATP-sensitive, voltage-dependent, or cal cium-activated K+ channels (Johnson et aI., 1998; Knot et aI., 1996; McCarron and Halpern, 1990) . There ap pears to be at least two components of the K+-induced cerebral vasodilator response (Edwards et aI., 1988; Mc Carron and Halpern, 1990) . A transient vasodilation is produced by very low concentrations of K+ (1 to 5 mmollL above control) and is blocked by ouabain, con sistent with hyperpolarization produced by activation of Na+-K+-ATPase (McCarron and Halpern, 1990) . In ad dition, a sustained vasodilator effect occurs in response to slightly higher concentrations of K+ (7 to 16 mmollL) and this component is blocked by barium (Edwards et aI., 1988; Johnson et aI., 1998; Knot et aI., 1996; McCarron and Halpern, 1990) . The concentration of barium needed to produce this effect «5 0 f,LmoIlL) appears to selec tively block inwardly rectifying K+ channels (Edwards et aI., 1988; Quayle et aI., 1993) , suggesting that the sus tained component of vasodilation in response to K+ is mediated by activation of inwardly rectifying K+ chan nels (Johnson et aI., 1998; Knot et aI., 1996) . It is be lieved that this latter mechanism occurs because of un usual gating properties of this ion channel, which are affected by the concentration of extracellular K+ as well as the membrane potential. Thus, a small increase in extracellular K+ leads to an increase in resting outward current through inwardly rectifying K+ channels, and hence hyperpolarization and vascular relaxation.
Hypoxia and hypercapnia
Hypoxia and hypercapnia are potent dilators in the cerebral circulation. Although it has been known for many years that these stimuli increase cerebral blood flow, mechanisms that mediate these responses have been difficult to define completely. Recent evidence sug gests that activation of K+ channels may contribute to cerebral vasodilation during hypoxia and hypercapnia.
Relaxation of the carotid artery (Taguchi et aI., 1995a) , large cerebral arteries (Fredricks et aI., 1994) , and cerebral arterioles (Shankar and Armstead, 1995; Taguchi et aI., 1994) in response to hypoxia is inhibited by glibenclamide. Increases in cerebral blood flow dur ing hypoxia are similarly reduced by inhibitors of ATP sensitive K+ channels (Reid et aI., 1993 (Reid et aI., , 1995 . Thus, activation of A TP-sensitive K+ channels appears to be important in mediating responses to hypoxia. Relaxation of the middle cerebral artery in response to hypoxia in vitro is inhibited by TEA, suggesting that calcium activated K+ channels (Gebremedhin et aI., 1994) may also contribute to hypoxia-induced vasorelaxation.
Activation of K+ channels may contribute to dilation of cerebral vessels during hypercapnia, although findings related to this stimulus have been inconsistent. Some studies suggest hypercapnia (or acidosis) relaxes cerebral vessels, in part, by activation of K+ channels (Faraci et aI., 1994; Kinoshita and Katusic, 1997; Kontos and Wei, 1996) . For example, relaxation of the basilar artery in response to acidosis was inhibited by a high concentra tion of KCI, barium, or glibenclamide (Kinoshita and Katusic, 1997) . Acidosis is known to hyperpolarize ce rebral arterioles, consistent with activation of K+ chan nels (Dietrich and Dacey, 1994) . In contrast, glibencl amide did not affect dilation of cerebral arterioles in response to low pH in other studies (Janigro et aI., 1997; Wahl et aI., 1994) . Thus, the overall importance of K+ channels in mediating vasorelaxation in response to hy percapnia/acidosis is not clear.
Reactive oxygen species
Reactive oxygen species (either applied directly in the case of hydrogen peroxide or produced enzymatically using xanthine-xanthine oxidase) produce dilation of ce rebral microvessels in vivo (Rosenblum, 1983; Sobey et aI., 1997b; Wei et aI., 1985 Wei et aI., , 1996 Yang et aI., 199 1a, 1991b) . Both arachidonic acid and bradykinin produce dilation of cerebral arterioles that is mediated by endog enous formation of reactive oxygen species (Faraci et aI., 1997; Kontos et aI., 1984; Rosenblum, 1987; Sobey et aI., 1997b) . Because intracellular production and concen trations of reactive oxygen species have not been mea sured in cerebral endothelium or vascular smooth muscle in vivo, the precise contribution of each reactive oxygen species (superoxide anion, hydrogen peroxide, and hy droxyl radical) as a mediator of the vasodilation is dif ficult to define. However, the pharmacologic profile ob tained using inhibitory agents such as superoxide dismu tase, catalase, and deferoxamine suggests that the primary mediator of vasodilation in response to brady kinin and arachidonic acid is hydroxyl radical or hydro gen peroxide, depending on the species (Kontos et aI., 1984 (Kontos et aI., , 1989 (Kontos et aI., , 1990 Rosenblum, 1987; Sobey et aI., 1997b; Yang et aI., 1991a) .
Recent experiments performed both in vitro and in vivo provide functional evidence that exogenously ap plied and endogenously produced reactive oxygen spe cies produce vasorelaxation that is mediated by activa tion of K+ channels (Faraci et aI., 1997; Iida and Sobey et aI., 1997b; Wei et aI., 1996) (Fig. 6 ) It is noteworthy that hydrogen peroxide also increases cAMP levels in the basilar artery (Iida and , sug gesting that effects of hydrogen peroxide on K+ channels in large arteries may not be direct but may be mediated by this second messenger system. Peroxynitrite, produced by the interaction of superox ide anion and NO (Fig. 6) , is a reactive nitrogen species that also produces dilation of cerebral arterioles (Wei et aI., 1996) . Studies in feline pial vessels suggest that di lation in response to peroxynitrite is also mediated by activation of K+ channels (Wei et aI., 1996) (Fig. 6 ).
PATHOPHYSIOLOGY K+ channel-mediated effects on blood vessels are altered during pathophysiology Several li'1es of evidence suggest that the function of K+ channels in cerebral blood vessels is altered in disease states. For example, relaxation of cerebral vessels in re sponse to activators of ATP-sensitive K+ channels is im paired during chronic hypertension (Kitazono et aI., 1993c) and diabetes (Mayhan, 1994; Mayhan and Faraci, 1993; Zimmerman et aI., 1997) and after ischemia (Bari et aI., 1996; Louis et aI., 1996) or brain injury (fluid percussion injury) (Armstead, 1997a [OW] ) and peroxynitrite (ONOO-) produce K+ channel-mediated relaxation of vascular smooth muscle. Poten tial sources of superoxide include cyclooxygenase (COX) (both COX-1 and COX-2), NO synthase (NOS) (NOS may produce superoxide in the absence of L-arginine or tetrahydrobiopterin), xanthine oxidase (XO), or reduced nicotinamide adenine di nucleotide (NADH) oxidase. Peroxynitrite is formed by the reac tion of superoxide with NO. Hydrogen peroxide is produced from superoxide by superoxide dismutases (SOD). Hydrogen peroxide is degraded by catalase but can also be catalyzed to OW radical by the Haber-Weiss reaction. Activation of K+ channels results in K+ efflux from the cell, hyperpolarization of the cell membrane, and closure of voltage-gated Ca2+ channels. Closure of Ca2+ channels reduces intracellular levels of Ca2+, producing relax ation of vascular smooth muscle.
may not be unique to ATP-sensitive K+ channels because brain injury also inhibits responses to NS-1619 and pi tuitary adenylate cyclase-activating peptide in the new born pig (both produce iberiotoxin-sensitive vasodilation in this model suggesting responses are mediated by cal cium-activated K+ channels) (Armstead, 1997d) . In ad dition, function of inwardly rectifying K+ channels also appears to be impaired in cerebral arteries after ischemia with reperfusion (Marrelli et aI., 1998) . In contrast, re sponses to NS-1619 and agents thought to activate cal cium-activated K+ channels (forskolin and cAMP) are not impaired by ischemia followed by reperfusion (Bari et a!., 1997) .
Functional effects of K+ channels in the cerebral cir culation are not always impaired in disease states. For example, basal activity of calcium-activated K+ channels appears to be enhanced during chronic hypertension (Liu et aI., 1998; Paterno et aI., 1997) . Data supporting this concept include the findings that inhibitors of calcium activated K+ channels produce greater constriction of the basilar artery and cerebral arterioles in vivo in chroni cally hypertensive rats (Liu et aI., 1998; Paterno et aI., 1997) .
The mechanisms that account for altered K+ channel mediated vascular responses are poorly defined. One possibility is altered expression of K+ -channel proteins, but very little is known regarding this potential mecha nism. Recent studies have provided evidence for changes J Cereb Blood Flow Metab, Vol. 18, No. 10, 1998 in expression of K+ channels at the mRNA and protein levels during chronic hypertension (Uu et aI., 1998; Yuan et aI., 1998a) and hypoxia (Wang et aI., 1997) . Other studies suggest that production of endothelin (Kas emsri and Armstead, 1997) and activation of protein ki nase C can inhibit activity of K+ channels (Lange et aI., 1997; Linde et aI., 1997) , including calcium-activated K+ channels driven by calcium sparks (Bonev et aI., 1997) . These latter findings are of interest as several patho physiologic conditions are associated with increased pro duction of endothelin and activation of protein kinase C.
K+ channels may be an important compensatory vasodilator mechanism
A concept that is emerging from recent studies is that K+ channels in the cerebral circulation may become functionally more important under some pathophysi ologic conditions (especially conditions associated with impairment of the NO-cGMP signaling pathway). Sev eral findings support this concept. First, NO produces hyperpolarization of the basilar artery in the presence, but not the absence, of an inhibitor of NO synthase (Mur phy and Brayden, 1995) . Hyperpolarization of the middle cerebral artery in response to NO is greater in vessels from diabetic compared with normal animals (Zimmerman et aI., 1997) . Second, inhibitors of K+ chan nels produce greater attenuation of relaxation of cerebral vessels in response to exogenous NO after inhibition of NO synthase or soluble guanylate cyclase than under control conditions (Onoue and Katusic, 1998b; Sobey and Faraci, 1997b) . Third, the functional importance of K+ channels appears to increase in disease states associ ated with impairment of endothelium-dependent (NO mediated) relaxation including subarachnoid hemorrhage (Harder et aI., 1987; Sobey et aI., 1996 Sobey et aI., , 1997b Zuc carello et aI., 1996) and hypercholesterolemia (Najibi and Cohen, 1995) . For example, inhibitory effects of charybdotoxin on vasorelaxation in response to NO are absent or modest in normal arteries but are enhanced after subarachnoid hemorrhage or in the presence of hy percholesterolemia (N ajibi and Cohen, 1995; Onoue and Katusic, 1998a) . Importantly, although several vasodila tor mechanisms are impaired after subarachnoid hemor rhage, relaxation of the basilar artery in response to ac tivators of potassium channels is preserved or enhanced (Ahmad et aI., 1996; Harder et aI., 1987; Hongo et aI., 1989; Imaizumi et aI., 1996; Inoue et aI., 1996; Sobey et aI., 1996 Sobey et aI., , 1997a Yanagisawa et aI., 1998; Zuccarello et aI., 1996) . These findings suggest that K+ channels are potentially important therapeutic targets in disease states, including cerebral vasospasm.
In summary, several K+ channels are present in cere bral blood vessels. Multiple lines of evidence suggest these ion channels are functionally important, contribut ing to regulation of basal tone and as key mediators of vasodilation. The expression and functional importance of K+ channels may change in disease states. Future stud ies should provide insight into the molecular biology of K+ channels in the cerebral circulation as well as their potential as therapeutic targets. 
